Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra ™ ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Robert Canby, a cardiac electrophysiologist, describes an FDA-approved novel lead-less system that provides cardiac ...

The major trials that established cardiac resynchronization therapy (CRT) as a treatment for heart failure (HF) with reduced ejection fraction (HFrEF) tended not to include patients who already had ...

St. Jude Medical announced Monday that the Minnesota device maker received FDA approvals for three new pacemakers. This means that American patients will be able to access its Allure Quadra Cardiac ...

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

"This puts CRT on equal footing with ACE inhibitors and beta blockers as part of the standard of care for patients with heart failure," Dr John GF Cleland (University of Hull, Kingston-upon-Hull, UK) ...

This week Cambridge Consultants unveiled a semi-leadless pacemaker it designed for start-up EBR Systems. The device, called Wireless Cardiac Stimulation system (WiCS), includes a leadless electrode ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

An implant the size of a watch that zaps the heart with electric pulses could help thousands of people with heart failure – by cleverly changing the organ’s source of fuel. Healthy hearts mostly burn ...